Introduction
============

Chondroma is a benign tumor, originating in chondrocytes. It is common in long bone, but rarely occurs in the lung parenchyma. The clinicopathological features of pulmonary chondroma has been rarely reported ([@b1-mco-0-0-945],[@b2-mco-0-0-945]). Bateson ([@b3-mco-0-0-945]) distinguished endobronchial chondroma from pulmonary chondroma based on the histogenesis of lung chondroma. The former grows into the bronchial lumen and accounts for \<25% of all benign cartilage neoplasms of the lung. The latter grows into lung parenchyma and has an incidence of about 0.1% of all benign lung tumor types. Between July 2003 and June 2015, 29 patients with pulmonary chondroma underwent surgical operation at The Affiliated Hospital of North Sichuan Medical College (Nanchong, China). All patients were pathologically diagnosed. The present paper aimed to summarize the clinicopathological features and the outcome of surgical treatment of pulmonary chondroma. Additionally, the present study clarified the differences between pulmonary chondroma and other benign pulmonary tumor.

Materials and methods
=====================

### Clinical data

The present study was approved by the Ethics Committee of North Sichuan Medical College (Nanchong, China). All patients provided written informed consent. The clinical data for each of the 29 patients is shown in [Table I](#tI-mco-0-0-945){ref-type="table"}. A total of 29 patients were pathologically diagnosed pulmonary chondroma, including 16 males and 13 females, with an average age of 57 years (range, 39--78-years-old). Of these patients, 18 exhibited no clinical symptoms and the pulmonary chondroma was detected by routine medical examination, 7 patients were characterized by coughing, hemoptysis, shortness of breath and other symptoms, only 3 patients presented with chest pain as the predominant symptom and 1 patient with esophageal cancer was identified by preoperative examination. Physical examination revealed only 3 patients with low breath sounds and others without obvious abnormalities. Lung tumor-like lesions, nodules and varying degrees of calcification was demonstrated by chest computed tomography (CT) scan ([Fig. 1](#f1-mco-0-0-945){ref-type="fig"}). No significant enlargement of the lymph nodes and pulmonary cavity was observed. Pulmonary masses of 9 patients were in the right lower lobe, 2 were in the right upper lobe, 3 were in the right middle lobe, 11 were in the left upper lobe and 4 were in the left lower lobe. The mean tumor diameter was 3.6 cm, ranging between 1.0 cm and 8.5 cm. The edge of the 8 cases were rough and the rest were smooth. No obvious abnormalities were revealed by other routine preoperative examinations, including head CT scan, radionuclide bone scan and abdominal ultrasound. Preoperatively, 13 patients were considered hamartoma, 14 patients were considered benign nodules, only 2 patients with chest wall adhesion were suspected of malignant infiltration and no patient was diagnosed pulmonary chondroma.

### Operative technique

The thoracotomy pneumonectomy was performed under general anesthesia with single-lung ventilation, which may be accomplished with double-lumen endotracheal tubes. The patients were placed in the lateral decubitus position with the upper arm suspended on a crossbar. Firstly, a 1.5 cm incision was placed in the seventh intercostal space at mid axillary line. The pleural cavity was entered to explore the lesion and surrounding structures. Another incision (\~7--9 cm long) was made in the fourth intercostal space under the armpit if there was no adhesion, or else anterolateral incision was used. During conventional thoracotomy, the mass revealed no malignant cells by intraoperative frozen section examination and was therefore confirmed as benign tumors.

### Statistical analysis

The data were analyzed using SPSS 22.0 (IBM SPSS, Chicago, IL, USA) and the results were presented as the mean ± standard deviation.

Results
=======

A total of 29 patients were pathologically diagnosed with pulmonary chondroma, including 16 males and 13 females, with an average age of 57 years (range, 39--78 years). Of these patients, 18 exhibited no clinical symptoms and the pulmonary chondroma was detected by routine medical examination, 7 were characterized by coughing, hemoptysis, shortness of breath and other symptoms, 3 patients presented with chest pain as the predominant symptom and 1 patient with esophageal cancer was identified by preoperative examination. Physical examination revealed only 3 patients with low breath sounds and others without obvious abnormalities. Lung tumor-like lesions, nodules and varying degrees of calcification was demonstrated by chest computed tomography (CT) scan ([Fig. 1](#f1-mco-0-0-945){ref-type="fig"}). No significant enlargement of the lymph nodes and pulmonary cavity was observed. Pulmonary masses of 9 patients were found in the right lower lobe, 2 were in the right upper lobe, 3 were in the right middle lobe, 11 were in the left upper lobe and 4 were in the left lower lobe. The mean tumor diameter was 3.6 cm, ranging between 1 and 8.5 cm. The edge of the 8 cases were rough and the rest were smooth. No obvious abnormalities were revealed by other routine preoperative examinations, including head CT scan, radionuclide bone scan and abdominal ultrasound. Preoperatively, 13 patients were considered hamartoma, 14 patients were considered benign nodules, 2 patients with chest wall adhesion were suspected of malignant infiltration and no patient was diagnosed with pulmonary chondroma.

A total of 11 patients underwent lobectomy ([Fig. 2](#f2-mco-0-0-945){ref-type="fig"}), 17 patients underwent segmentectomy and 1 patient used lump stripping. They were postoperatively pathologically diagnosed as pulmonary chondroma ([Fig. 3](#f3-mco-0-0-945){ref-type="fig"}). All the lymph nodes were reactive hyperplasia. Carney\'s triad was excluded by abdominal magnetic resonance imaging (MRI) and gastroscopy. No mortality occurred during surgery. The operative duration ranged between 48 and 215 min (mean, 126±22 min). The estimated blood loss ranged between 5 and 350 ml (mean, 82±23 ml). Additionally, no patient required a blood transfusion. All patients, with the exception of 5 patients, had an uneventful postoperative course (82.8%). Of the five complications, two were postoperative encapsulated pleural effusion and three were pulmonary infection. These 5 patients recovered well following percutaneous catheter drainage by CT-guided and anti-infection therapy. The drainage duration ranged between 2 and 8 days (mean, 3.1±1.8 days) and the postoperative hospital duration ranged between 4 and 13 days (mean, 4.0±2.1 days). Patients were followed-up between 2 and 135 months. During follow-up, 23 patients were alive without recurrence, 1 patient succumbed to esophageal cancer after 19 months post-surgery, 3 patients succumbed to other diseases. A total of 2 patients were lost during follow-up.

Discussion
==========

Pulmonary chondroma is often originated from ectopic cartilage of lung tissue during embryonic development. Chondrocytes in other parts of the tissues flowed into the lungs by bloodstream. Connective tissues, reticulocytes developed into original direction by certain stimulate conditions, became the embryo of mesenchymal tissue, and then developed into chondrocytes. These are theoretical speculations ([@b2-mco-0-0-945]).

The tumor tissues were pale and translucent, hard and lobulated on the lateral section. Under the microscope, the tumors were observed to be formed by differentiation of mature cartilage tissue, wrapped around the cartilage matrix. Cartilage tissues can be hyaline cartilage, elastic cartilage and fibrous cartilage, or diverse cartilage mixed together without other mesenchymal tissue components, abnormal mitotic and adipose tissues. Chondrocytes can encounter calcification, ossification and mucoid degeneration ([@b4-mco-0-0-945]).

A few case reports have identified pulmonary chondroma ([@b1-mco-0-0-945],[@b2-mco-0-0-945]). Only 0.04% of lung neoplasms were identified to be pulmonary chondroma ([@b3-mco-0-0-945]). Pulmonary chondroma was common in adult females of 40--50-years-old and neonatal cases were occasionally reported ([@b2-mco-0-0-945]). However, in the present group, 16 males and 13 females with an average age of 57 years (range, 39--78-years-old), different from the literature ([@b2-mco-0-0-945],[@b4-mco-0-0-945],[@b5-mco-0-0-945]). Pulmonary chondroma may occur in each pulmonary lobe, particularly the right lower lobe. Of the 29 patients, 9 exhibited pulmonary chondroma located in the right lower lobe and 15 were located in left lung, also inconsistent with previous literature. The mean diameter of pulmonary chondroma was 2.8 cm and was usually asymptomatic ([@b4-mco-0-0-945]). In the present study, the average diameter was 3.6 cm (1.0--8.5 cm). Of the patients, 18 presented without any clinical symptoms, 1 with esophageal cancer was identified by preoperative examination. The symptoms of pulmonary chondroma depended on the size and location of the tumor. If the bronchus were oppressed, atelectasis was caused. Respiratory symptoms, including cough with sputum or hemoptysis and shortness of breath, can occur ([@b6-mco-0-0-945],[@b7-mco-0-0-945]). In the present study, 7 cases (13.8%) occurred. In addition, 3 patients exhibited chest pain. From the CT scan, the tumor size in all three patients were larger and exhibited chest wall invasion. Intraoperatively, the tumor shrunk without invasion into the chest wall. As a result of the compression of intercostal nerves, the patients encountered chest pain ([@b8-mco-0-0-945]).

Generally, pulmonary chondroma is one of the clinical features of Carney\'s triad. Carney *et al* ([@b9-mco-0-0-945]) first reported the disease in 1977. This study included gastrointestinal stromal tumor, pulmonary chondroma, extra-adrenal paraganglioma. If 2/3 clinical features are present, it can be diagnosed as Carney\'s triad ([@b9-mco-0-0-945]). Clinically, 2 features were often observed in *\~*78% of patients ([@b5-mco-0-0-945]). Generally, gastrointestinal stromal tumors merged with pulmonary chondroma occurred more often in \~53%. The syndrome is rare and predominantly affects young women; however, the etiology remains unknown. Surgical resection was the predominant treatment, which has a higher postoperative survival. A total of 104 patients with Carney\'s triad were reported to have survival rates of 10 and 40 years, for 100 and 73%, respectively ([@b10-mco-0-0-945]). For young women, a gastrointestinal stromal tumor or pulmonary chondroma should be considered as one of the clinical features of Carney\'s triad. In addition, gastrointestinal stromal tumors and extra-adrenal paraganglioma in Carney\'s triad were potentially fatal, and eliminating the syndrome for patients with pulmonary chondroma was necessary. The correct diagnosis for patients of Carney\'s triad is essential to provide the appropriate treatment and result in a good prognosis. To exclude Carney\'s triad, the 29 patients in the present study underwent abdominal MRI examination and gastroscopy 3 months after surgery and no abnormalities were detected. As a result of the heterochrony of the three tumors, lifelong follow-up of patients with pulmonary chondroma is necessary.

A chest X-ray, enhanced CT scan of the chest or MRI made it easier to identify the benign or malignant calcification lumps. The CT is more commonly used, often displaying as round or oval nodules, moderate soft tissue density, inhomogeneous density with calcification and clear boundaries. Tumor diameter often ranged between 1.0 and 4.0 cm with mild lobulation. No glitches, satellite lesions or enlarged lymph nodes at the hilus of lung or mediastinum were observed ([@b11-mco-0-0-945]). In the present study, patients with enhanced CT scan presented similarly with those in the literature. Ultimately, pathological diagnosis of the tumor is required.

Pulmonary chondroma can be easily misdiagnosed as tuberculosis tumor, hamartoma (particularly cartilage hamartoma) and peripheral lung cancer. In the present study, varying degrees of calcification were observed in all cases. A total of 13 patients were considered to have hamartoma, 14 patients were considered to exhibit benign nodules, 2 patients with chest wall adhesion were suspected of malignant infiltration and all patients were not diagnosed as pulmonary chondroma.

Patients with a previous history of tuberculosis was usually considered to have pulmonary tuberculoma ([@b12-mco-0-0-945]). Tuberculoma was often located in the dorsal segment of the lower lobe. Calcifications and cavity were found in the lesion and were characterized by circular structures by enhanced CT scan. The most common benign tumor of the lung was hamartoma, which accounted for 5--10% of solitary pulmonary nodules ([@b13-mco-0-0-945]). Calcification looked like popcorn or the image of fat density with enhanced CT scan and allowed the differentiation of points of hamartoma. Notably, calcification of pulmonary chondroma was smaller, mostly point-like or scaly. In the present study, 13 patients (44.8%) were misdiagnosed as having hamartoma. For older individuals who smoked perennially, a cough with sputum and blood may easily be misdiagnosed as peripheral lung cancer. Enhanced CT scans revealed a burr-like structure of the tumor, pleural indentation and inhomogeneous enhancement often accompanied by enlarged lymph nodes at the hilus of the lung or mediastinum ([@b14-mco-0-0-945]). Although the average age in the present study was older, varying degrees of calcification were revealed in the CT. Only 2 patients with chest wall adhesion were suspected of malignant infiltration. In addition, previous medical history, including primary malignant tumor and solitary pulmonary metastases, was difficult to identify with non-calcified pulmonary chondroma.

Although primary lung tumors are benign tumors of cartilage, there remains the possibility of malignant transformation. Mei *et al* ([@b15-mco-0-0-945]) reported a case of giant primary mesenchymal chondrosarcoma of the lung, followed-up for 6 months and this patient succumbed to tumor recurrence and metastasis ([@b15-mco-0-0-945]). Certain patients succumb to Carney\'s triad as a result of malignant alteration of lesions. Therefore, the patients with Carney\'s triad must be given a medical check periodically. It was more difficult to identify malignant pulmonary chondroma with chondrosarcoma on the image presentations. Surgical resection was the preferred treatment for pulmonary chondroma. With the advantages of less trauma and faster recovery, thoracoscopy or subaxillary minithoracotomy was used as the preferred treatment ([@b16-mco-0-0-945]). In the present study, 23 cases were completely resected without residual tumor or postoperative recurrence.

Pulmonary chondroma is a rare benign tumor of the lung and the etiology remains unknown. It grows slowly with hidden clinical symptoms, often identified by routine medical examination. Pulmonary chondroma can be easily misdiagnosed as a tuberculosis tumor, hamartoma (particularly cartilage hamartoma) and peripheral lung cancer. As a result of the possibility of the malignant transformation, complete surgical resection is the best treatment. Pulmonary chondroma are possibly an initial clinical presentation of Carney\'s triad; therefore, following the diagnosis of pulmonary chondroma, further examination is required to exclude the Carney\'s triad.
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![Contrast-enhanced computed tomography revealed a large inhomogeneous density mass with varying degrees of calcification.](mco-05-03-0211-g00){#f1-mco-0-0-945}

![Images of the resected mass. (A) Patients with pulmonary chondroma underwent lobectomy intraoperatively. (B) The mass was pale and translucent, hard, and lobulated on the lateral section.](mco-05-03-0211-g01){#f2-mco-0-0-945}

![Hematoxylin and eosin staining of tumor cells. The tumor was revealed to be formed by differentiation of mature cartilage tissue wrapped around by cartilage matrix (magnification, ×200).](mco-05-03-0211-g02){#f3-mco-0-0-945}

###### 

Clinical data.

  Patient no.   Age (years)   Gender   Size (cm)   Operative time (min)   Blood loss (ml)   Drainage (days)   Follow-up                              Position            Preoperative diagnosis
  ------------- ------------- -------- ----------- ---------------------- ----------------- ----------------- -------------------------------------- ------------------- ------------------------
    1           51            M        2.3           64                     45              3                 Alive without recurrence               Right lower lobe    Hamartoma
    2           43            F        4.6           78                     30              4                 Alive without recurrence               Right lower lobe    Benign nodules
    3           38            M        5.2         155                      10              2                 Succumbed to non-neoplastic diseases   Right upper lobe    Hamartoma
    4           62            M        1.4           92                   100               2                 Alive without recurrence               Right middle lobe   Benign nodules
    5           53            M        1           146                      60              3                 Alive without recurrence               Right lower lobe    Hamartoma
    6           68            F        3.9         104                        5             3                 Alive without recurrence               Left lower lobe     Hamartoma
    7           56            F        4.4         132                      50              3                 Alive without recurrence               Right upper lobe    Benign nodules
    8           57            F        2.3         141                    120               2                 Succumbed to non-neoplastic diseases   Right lower lobe    Hamartoma
    9           72            F        6.8         137                      80              2                 Alive without recurrence               Left upper lobe     Benign nodules
  10            52            M        4.1           48                     30              2                 Alive without recurrence               Right lower lobe    Hamartoma
  11            47            F        2.6         164                      90              4                 Lost                                   Right lower lobe    Malignant tumor
  12            78            M        6.9         143                    180               3                 Alive without recurrence               Left upper lobe     Benign nodules
  13            64            M        1.8         156                      40              4                 Alive without recurrence               Left upper lobe     Benign nodules
  14            73            F        3           123                      30              2                 Lost                                   Right middle lobe   Hamartoma
  15            66            M        2.5         157                      75              5                 Alive without recurrence               Left lower lobe     Benign nodules
  16            69            F        5           129                    350               2                 Alive without recurrence               Right lower lobe    Benign nodules
  17            64            M        8.5           92                     40              3                 Succumbed to non-neoplastic diseases   Right middle lobe   Benign nodules
  18            57            F        3.8         201                      60              2                 Alive without recurrence               Left upper lobe     Benign nodules
  19            52            F        3.2         107                      80              8                 Alive without recurrence               Left lower lobe     Hamartoma
  20            55            M        1.9         215                    240               3                 Alive without recurrence               Right lower lobe    Hamartoma
  21            58            M        1.8         104                      30              4                 Alive without recurrence               Left upper lobe     Malignant tumor
  22            46            F        3.7         106                      50              3                 Succumbed to non-neoplastic diseases   Left upper lobe     Hamartoma
  23            70            F        2.2         192                      40              3                 Alive without recurrence               Left lower lobe     Benign nodules
  24            51            M        3.2         104                      45              3                 Alive without recurrence               Left upper lobe     Benign nodules
  25            48            M        1.2         174                    100               2                 Alive without recurrence               Left upper lobe     Hamartoma
  26            59            F        7.4         117                      80              5                 Alive without recurrence               Right lower lobe    Hamartoma
  27            54            M        2.3           94                   100               3                 Alive without recurrence               Left upper lobe     Benign nodules
  28            43            M        4.2           89                   160               2                 Alive without recurrence               Left upper lobe     Benign nodules
  29            47            M        3.2           90                     55              3                 Alive without recurrence               Left upper lobe     Hamartoma

M, male; F, female.
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